Primary Hyperoxaluria Type 2 (PH2)
2 clinical trials · Condition
◉ Watch Primary Hyperoxaluria Type 2 (PH2)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 (NCT03847909) | Novo Nordisk A/S | 2019-10-28 |
| Long Term Extension Study in Patients With Primary Hyperoxaluria (NCT04042402) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2019-07-09 |
Track Primary Hyperoxaluria Type 2 (PH2) automatically
Every clearance here is in the API, with alerts when new ones post.